HAITONG SEC Research Reports point out that BYD (002594.SZ) is expected to achieve a Net income of 40.3 billion yuan in 2024, an increase of 34% year-on-year. Among them, the Q4 of 2024 is expected to achieve a Net income of 15 billion yuan, an increase of 73% year-on-year and 29% quarter-on-quarter. BYD is projected to deliver a total of 4.27 million new cars in 2024, an increase of 41% year-on-year, with 1.54 million cars delivered in Q4 2024, an increase of 63% year-on-year and 36% quarter-on-quarter. The first batch of 21 models of the Heavenly Eye C has been officially launched, marking the beginning of the Q&M Dental era of intelligent driving. As a leading company in the Electric Vehicles Industry, BYD is vigorously promoting intelligent driving, which is beneficial for the entire industry to reduce R&D and production costs, thereby promoting the broader adoption of intelligent driving. Additionally, the Super E platform technology has been released, and the Han and Tang L models have opened a new cycle of pure electric vehicles. An employee stock ownership plan has been launched to support long-term development. Considering comparable companies and the fact that BYD is a leading Electric Vehicles company, a PE ratio of 21-22 times is given for the company in 2025, corresponding to a reasonable value Range of 383.02-401.26 yuan. Maintaining the "Outperform the Market" rating.
Clear
All
Quotes
News
Learn
Help
All
HK
US
CN
SG
AU
JP
All
News
Announcements
Reports
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh
Refresh
Loading
History record
Latest News
-
U.S. stock market closing | Concerns over tariffs and inflation pressured the three major indexes, with the Nasdaq falling nearly 3%; Google and Palantir dropped nearly 5%; NVIDIA's "favorite child" CoreWeave's debut was a rollercoaster.
Weekend reading | The path to POP MART's trillion goal: being an agent for LABUBU, expanding product categories, and going to the large market.
This week in Hong Kong stocks | The Innovative Drugs Sector in Hong Kong has exploded! Tongyuan Kang Pharmaceutical surged 25% this week, while 3SBIO rose nearly 19%; TCL ELECTRONICS exceeded expectations with a cumulative increase of nearly 20% this week
Quotes
More
News
More
Learn
More
Help
More
Loading
News
More
Announcements
More
Reports
More
海通证券:维持比亚迪“优于大市”评级,目标价383.02-401.26元
HAITONG SEC: Maintains BYD's "Outperform the Market" rating with a Target Price of 383.02-401.26 yuan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Like
Views 290
Write a comment
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Comment(0)
Reason For Report